|
TAF9B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.47220000004766E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.424000E-04 |
| Normal-vs-Stage2 |
3.262400E-02 |
| Normal-vs-Stage3 |
4.256900E-03 |
| Normal-vs-Stage4 |
7.37219999491501E-08 |
| Stage1-vs-Stage2 |
4.622800E-01 |
| Stage1-vs-Stage3 |
2.826000E-01 |
| Stage1-vs-Stage4 |
1.563120E-03 |
| Stage2-vs-Stage3 |
9.476200E-01 |
| Stage2-vs-Stage4 |
4.258600E-01 |
| Stage3-vs-Stage4 |
3.628600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.54969999999599E-05 |
| Normal-vs-AfricanAmerican |
6.24789997516473E-09 |
| Normal-vs-Asian |
6.252400E-02 |
| Caucasian-vs-AfricanAmerican |
2.136400E-03 |
| Caucasian-vs-Asian |
8.720400E-01 |
| AfricanAmerican-vs-Asian |
3.073800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99750999999582E-05 |
| Normal-vs-Female |
1.008080E-04 |
| Male-vs-Female |
6.400200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.92259999999678E-05 |
| Normal-vs-Age(41-60Yrs) |
1.793490E-04 |
| Normal-vs-Age(61-80Yrs) |
1.640600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.087810E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.500600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.880050E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.699200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.395000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.423400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.438600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.734800E-01 |
| Normal-vs-Grade 2 |
1.064590E-01 |
| Normal-vs-Grade 3 |
7.04350000546583E-08 |
| Normal-vs-Grade 4 |
6.23534557320227E-12 |
| Grade 1-vs-Grade 2 |
2.981200E-01 |
| Grade 1-vs-Grade 3 |
2.367800E-02 |
| Grade 1-vs-Grade 4 |
2.434200E-04 |
| Grade 2-vs-Grade 3 |
4.176100E-03 |
| Grade 2-vs-Grade 4 |
2.56269999998615E-07 |
| Grade 3-vs-Grade 4 |
7.785400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.604400E-01 |
| Normal-vs-ccB subtype |
4.94019999996986E-06 |
| ccA subtype-vs-ccB subtype |
1.614830E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.779670E-03 |
| Normal-vs-N1 |
2.943900E-03 |
| N0-vs-N1 |
2.072400E-01 |
|
|
